Comparison of two chemotherapy regimens, with or without cyclosporin A, in relapsed/refractory acute myeloid leukaemia: Results of the UK Medical Research Council AML-R trial.

被引：0
|
作者：
Yin, JAL
Wheatley, K
Rees, J
Burnett, A
机构：
[1] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
[2] CTSU Oxford, Oxford, England
[3] Addenbrookes Hosp, Cambridge, England
[4] Univ Wales Coll Med, Cardiff CF4 4XN, S Glam, Wales
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
946
引用
收藏
页码：231A / 231A
页数：1
相关论文
共 50 条
  • [1] Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial
    Yin, JAL
    Wheatley, K
    Rees, JKH
    Burnett, AK
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 713 - 726
  • [2] Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): Results of the UK Medical Research Council AML-R trial'
    Smith, BD
    Karp, J
    Burke, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 164 - 165
  • [3] Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial
    Gibson, Brenda E. S.
    Webb, David K. H.
    Howman, Andrew J.
    De Graaf, Siebold S. N.
    Harrison, Christine J.
    Wheatley, Keith
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 366 - 376
  • [4] Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
    Webb, DKH
    Wheatley, K
    Harrison, G
    Stevens, RF
    Hann, IM
    LEUKEMIA, 1999, 13 (01) : 25 - 31
  • [5] Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
    DKH Webb
    K Wheatley
    G Harrison
    RF Stevens
    IM Hann
    Leukemia, 1999, 13 : 25 - 31
  • [6] Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
    Burnett, Alan K.
    Russell, Nigel H.
    Hills, Robert K.
    Hunter, Ann E.
    Kjeldsen, Lars
    Yin, John
    Gibson, Brenda E. S.
    Wheatley, Keith
    Milligan, Donald
    Kjeldsen, Lars
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) : 3360 - +
  • [7] Factors relating to the achievement of complete remission (CR) in younger patients with acute myeloid leukaemia (AML) in the United Kingdom Medical Research Council (MRC) AML 10 trial.
    Wheatley, K
    Burnett, AK
    Goldstone, AH
    Hann, M
    Stevens, RF
    Rees, JKH
    Rees, JKH
    Gray, RG
    BLOOD, 1996, 88 (10) : 843 - 843
  • [8] A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial
    Russell, Nigel H.
    Hills, Robert K.
    Kjeldsen, Lars
    Clark, Richard E.
    Ali, Sahra
    Cahalin, Paul
    Thomas, Ian F.
    Burnett, Alan K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (03) : 528 - 534
  • [9] Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML Trial
    Stevens, RF
    Hann, IM
    Wheatley, K
    Gray, RG
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 130 - 140
  • [10] Attempts to Optimise Induction and Consolidation Chemotherapy in Patients with Acute Myeloid Leukaemia: Results of the MRC AML15 Trial.
    Burnett, Alan K.
    Hills, Robert K.
    Milligan, Donald
    Hunter, Ann E.
    Goldstone, Anthony H.
    Prentice, Archie
    Gibson, Brenda E. S.
    Kjeldsen, Lars
    Yin, John A. L.
    Wheatley, Keith
    Russell, Nigel H.
    BLOOD, 2009, 114 (22) : 200 - 200
12345